Corporate Overview
LENZ Therapeutics is a pre-commercial biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop to improve near vision in people with presbyopia.
Latest Financial Results
Q3 2024
Quarter Ended Sep 30, 2024
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2023
Report Links
Email Alerts
Get the latest news and reports delivered right to your inbox.
Sign Up TodayIR Contacts
Corporate
LENZ Therapeutics, Inc.
201 Lomas Santa Fe Drive
Suite 300
Solana Beach, CA 92075
T: (888) 928-LENZ (5369)
contact@lenz-tx.com
Investor Relations
LENZ Therapeutics
IR@LENZ-Tx.com
Stern Investor Relations, Inc.
Janhavi Mohite
janhavi.mohite@sternir.com
Transfer Agent
Equiniti Trust Company, LLC
48 Wall Street
New York, NY 10005
T: 800-937-5449